Humans already alter their own brain states — coffee boosts focus and alcohol relaxes.
Neurotech could deliver the same effects with precision and without the systemic risks.
Read about how neurotech can expand from purely clinical to consumer use ⬇️
zenodo.org/records/201196…
PL Capital
166 posts
We back computing breakthroughs early.
- PL Capital repostedWe’re pleased to be part of the ecosystem supporting @Mastercard's Agent Pay for Machines. By partnering with Mastercard, t54 brings its trust layer to Agent Pay for Machines, helping make agent-led payments more secure, auditable, and accountable.
- With a $500M war chest at a $2.5B valuation, @flourishailabs is on a mission to crack the brain’s core algorithm and usher in an era of low-power general intelligence inspired by biology. If anyone can pull it off, it’s this team. Proud to be an early backer.
- PL Capital repostedGreat podcast episode, @juanbenet & @JacquesCarolan! 👏🎬 QQ: At min 1:15 you describe a 3 dimensional plot between invasiveness, functionality, & data precision - AI made a v0, but would love your thoughts on a domain map for charting opportunity spaces! youtu.be/YpqVcD6tc5U?si…
- PL Capital repostedAwesome to hear how @sternhenri and the team at @privy_io are leveraging the platform and brand of @stripe post acquisition to accelerate the adoption of stablecoins and the achievement of their founding goal of allowing anyone to have more ownership and control over theirStablecoins are useless unless they solve actual business problems. Privy CEO Henri Stern reveals why Stripe acquired his company to build dominant global money rails. (0:00) Why are we even building with stablecoins? (0:36) What are Stripe's digital asset accounts? (2:04) How
00:00 - PL Capital repostedspilling all the tea on how to craft your perfect pitch 🤫Great products get built. Great narratives get funded. Today, @lacey_wisdom of PL Capital and Cointelegraph Accelerator's Viktor Y. will explore why the strongest pitch decks connect product, market, traction, and team into a single investable argument. • Traction-driven
- PL Capital repostedi think there are huge opportunities for neurotech at the intersection of engineered bio and hardware. e.g. can we combine the ability of certain biological systems (cells/aavs) to cross the bbb, target specific brain regions, evade the immune system with the controllability &Most neurotech approaches require opening the skull. @ARIA_research's £50m Massively Scalable Neurotechnologies program is asking the field whether high-performance neurotechnology can be delivered to the brain in a 30-minute outpatient procedure without transcranial surgery.
00:00 - PL Capital repostedDBS has been FDA-approved for 25 years and is covered by most insurance. But only ~ 0.1% of Parkinson's patients receive it. Jacques Carolan at @ARIA_research is working to close that gap. Full conversation with @JacquesCarolan on the @juanbenet Podcast >>>
00:00 - PL Capital repostedAwesome to see Paris 2.0 from @bageldotcom released today. It proves that image generation can be trained on a geographically distributed, heterogeneous pool of GPUs and outperform monolithic architecture and increasingly can anchor the world models powering physical AI 🥯🥯🗼🗼
- PL Capital repostedCrypto fundraising in 2026 looks nothing like it did two years ago. The rules have shifted. The capital sources have changed. And the playbook most founders are still using is out of date. @vineetbudki (@Sigma_VC ), @benlakoff (@BanklessVC), @itsbrendanma (@arbitrum), and
- PL Capital repostedThe world has an energy deficit, and Glow can convert dollars into net-new energy more efficiently than any other program on the planet.
- PL Capital repostedToday we're launching Simple Compute Market (SCM). The market is simple: agents find compute, negotiate, settle, and get access without a human driving every step. Open-source. Agent-driven. Public good. No token. No fees.
00:00 - "How many miracles do you need to have happen to make this thing work?" @JacquesCarolan runs two neurotech programs at @ARIA_research: one targeting brain circuit disorders with molecular precision, one aiming to deliver high-performance BCI without opening the skull. £119M inEpisode 3 of my new podcast features Dr. Jacques Carolan (@JacquesCarolan), a founding Program Director at ARIA (@ARIA_research), the UK’s Advanced Research and Invention Agency. He directs two neurotech programs aimed at one of the most important opportunity spaces: developing
00:00






















